A new trading day began on Friday, with Arcutis Biotherapeutics Inc (NASDAQ: ARQT) stock price down -3.70% from the previous day of trading, before settling in for the closing price of $9.45. ARQT’s price has ranged from $1.76 to $15.21 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 303.42% over the past five years. Meanwhile, its annual earnings per share averaged 37.10%. With a float of $97.27 million, this company’s outstanding shares have now reached $114.97 million.
Let’s look at the performance matrix of the company that is accounted for 296 employees.
Arcutis Biotherapeutics Inc (ARQT) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Arcutis Biotherapeutics Inc is 15.40%, while institutional ownership is 84.39%. The most recent insider transaction that took place on Mar 04 ’24, was worth 199,994. In this transaction Director of this company bought 21,052 shares at a rate of $9.50, taking the stock ownership to the 8,785,284 shares. Before that another transaction happened on Mar 04 ’24, when Company’s insider sold 14,903 for $11.12, making the entire transaction worth $165,739. This insider now owns 874,533 shares in total.
Arcutis Biotherapeutics Inc (ARQT) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around 37.10% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 9.80% during the next five years compared to -48.07% drop over the previous five years of trading.
Arcutis Biotherapeutics Inc (NASDAQ: ARQT) Trading Performance Indicators
Here are Arcutis Biotherapeutics Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 6.80.
Technical Analysis of Arcutis Biotherapeutics Inc (ARQT)
Arcutis Biotherapeutics Inc (NASDAQ: ARQT) saw its 5-day average volume 2.9 million, a negative change from its year-to-date volume of 4.78 million. As of the previous 9 days, the stock’s Stochastic %D was 10.76%. Additionally, its Average True Range was 0.91.
During the past 100 days, Arcutis Biotherapeutics Inc’s (ARQT) raw stochastic average was set at 64.33%, which indicates a significant increase from 14.04% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 103.28% in the past 14 days, which was lower than the 104.64% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $9.92, while its 200-day Moving Average is $6.52. Nevertheless, the first resistance level for the watch stands at $9.56 in the near term. At $10.02, the stock is likely to face the second major resistance level. The third major resistance level sits at $10.58. If the price goes on to break the first support level at $8.54, it is likely to go to the next support level at $7.98. The third support level lies at $7.52 if the price breaches the second support level.
Arcutis Biotherapeutics Inc (NASDAQ: ARQT) Key Stats
With a market capitalization of 1.05 billion, the company has a total of 96,813K Shares Outstanding. Currently, annual sales are 59,610 K while annual income is -262,140 K. The company’s previous quarter sales were 13,530 K while its latest quarter income was -66,280 K.
